Carobomer Based Controlled Release Designs of Atorvastatin Calcium Tablets Evaluated Using Quality by Design (QbD) Approach

Journals Menu

Follow SCIRP

ISSN Print: 2156-8251
ISSN Online: 2156-8278
www.scirp.org/journal/ajac
E-mail: ajac@scirp.org

"Carobomer Based Controlled Release Designs of Atorvastatin Calcium Tablets Evaluated Using Quality by Design (QbD) Approach"
written by Arunkanth Krishnakumar Nair, Peddakotla Venkata Ramana, P. Venkat Bhaskar Rao, Bapatu Hanimi Reddy, Hari Kishan Reddy Ganthi, Useni Reddy Mallu,
published by American Journal of Analytical Chemistry, Vol.8 No.3, 2017

has been cited by the following article(s):

[1]	Using the AQbD Approach, Development and Validation of a Simple, Rapid Stability Indicating Chromatographic Method for Quantification of Related Impurities of …
	Journal of Chromatographic Science, 2023

[2]	Utilizing Quality by Design to Develop and Evaluate Extended-Release Upadacitinib Tablets Incorporating a Biosynthesized Polymer
	Journal of Pharmaceutical Innovation, 2023

[3]	Development and evaluation of sustained release matrix tablets of pregabalin: A case study based on quality by design to analyze the impact of variables.
	Pakistan Journal of …, 2023

[4]	Controlled Release Formulation of Tofacitinib Citrate Tablets Evaluated Using Quality by Design (QBD) Approach
	Journal of Pharmaceutical …, 2021

[1]	Using the AQbD Approach, Development and Validation of a Simple, Rapid Stability Indicating Chromatographic Method for Quantification of Related Impurities of Apixaban Journal of Chromatographic Science, 2024 DOI:10.1093/chromsci/bmad065

[2]	A QBD WITH THE FRACTIONAL FACTORIAL DESIGN WAS USED TO MATCH THE SIMILARITY BETWEEN RANOLAZINE EXTENDED-RELEASE TABLETS 500 MG AND 1000 MG International Journal of Applied Pharmaceutics, 2023 DOI:10.22159/ijap.2023v15i2.47241

[3]	Utilizing Quality by Design to Develop and Evaluate Extended-Release Upadacitinib Tablets Incorporating a Biosynthesized Polymer Journal of Pharmaceutical Innovation, 2023 DOI:10.1007/s12247-023-09754-1

[4]	Utilizing Quality by Design to Develop and Evaluate Extended-Release Upadacitinib Tablets Incorporating a Biosynthesized Polymer Journal of Pharmaceutical Innovation, 2023 DOI:10.1007/s12247-023-09754-1

Follow SCIRP